Hal qayb oo ka mid ah Array BioPharma Inc, binimetinib, Braftova, encorafenib, Mektovi, Pfizer
Encorafenib oo leh binimetinib waxa ansixisay FDA si loogu daweeyo kansarka sanbabada unug yar-yar oo leh isbeddel BRAF V600E
Maamulka Cuntada iyo Dawooyinka (FDA) waxay ansixiyeen Encorafenib (Braftovi, Array BioPharma Inc., oo ah shirkad hoos timaada Pfizer) iyo binimetinib (Mektovi, Array BioPharma Inc.) bishii Noofambar 2023 sida daawooyinka loo isticmaali karo ...
Bosulif, Bosutinib, leukemia-da xuubka ah ee joogtada ah, CML, Pfizer
Bosutinib waxa u ansixisay FDA bukaanada carruurta ee qaba leukemia-da daba-dheeraada
Noofambar 2023: Bukaannada carruurta ee da'doodu tahay hal sano iyo ka badan oo qaba marxaladda dabadheeraad (CP) Ph+ chronic myelogenous leukemia (CML), ha ahaato kuwa dhowaan la baaray (ND) ama adkaysi u leh ama u adkaysan la' (R/I) daawaynta hore, Maamulka Cuntada iyo Dawooyinka. .
Pfizer, TALAPRO-2, Talazoparib
Talazoparib oo leh enzalutamide waxa u ansixisay FDA ee HRR hidda-socod-is-beddelay kansarka qanjirka 'prostate'.
July 2023: The Food and Drug Administration cleared talazoparib (Talzenna, Pfizer, Inc.) with enzalutamide for homologous recombination repair (HRR) gene mutations in metastatic castration-resistant prostate cancer (mCRPC). TALAP..
ADVL0912, anaplastic lymphoma kinase, qanjiro, NCT00939770, Pfizer, Xalkori
Crizotinib waxa u ansixisay FDA for ALK-positive buro myofibroblastic bararka
Julaay 2022: Crizotinib (Xalkori, Pfizer Inc.) waxa siisay ogolaanshaha Maamulka Cuntada iyo Dawooyinka (FDA) ee daawaynta dadka waaweyn iyo bukaanada carruurta 1 sano jir ah iyo kuwa ka wayn kuwaas oo laga helay cudurka aan la daabicin, soo noqnoqda.
ALK, B7461006, Crizotinib, Lorbrena, lorlatinib, NCT03052608, Pfizer, Ventana ALK, Nidaamyada Caafimaadka ee Ventana
Lorlatinib waxaa ansixiyay FDA si loogu daaweeyo ALSC-positive NSCLC.
Ogosto 2021: Lorlatinib (Lorbrena, Pfizer Inc.) waxay heshay oggolaansho joogto ah oo FDA ah oo loogu talagalay bukaannada qaba kansarka sanbabada ee unugyada yar-yar (NSCLC) oo burooyinkoodu yihiin lymphoma kinase anaplastic kinase (ALK), sida uu go'aamiyay FDA-app.
anaplastic lymphoma kinase, B7461006, CDx assay, Maamulka Cuntada iyo Dawooyinka, Lorbrena, lorlatinib, NCT03052608, NSCLC, Pfizer, Ventana ALK, Nidaamyada Caafimaadka ee Ventana
Lorlatinib waxaa ansixiyay FDA si loogu daaweeyo ALSC-positive NSCLC
Ogosto 2021: Lorlatinib (Lorbrena, Pfizer Inc.) waxay heshay oggolaansho joogto ah oo FDA ah oo loogu talagalay bukaannada qaba kansarka sanbabada ee unugyada yar-yar (NSCLC) oo burooyinkoodu yihiin lymphoma kinase anaplastic kinase (ALK), sida uu go'aamiyay FDA-app.
Bharat Biotech, Coronavirus, Covaxin, Covid, Talaalka covid, Covichield, Pfizer
Tallaalka COVID-19 - Dhammaan wixii aad dooneysay inaad ogaato
Dr. Julie Gralow ayaa ka jawaabtay su'aalaha ku saabsan tallaalka COVID-19. Sideen ku hubin karnaa in tallaaladu badbaadsan yihiin haddii la soo saaray oo lagu ansixiyay muddo gaaban gudaheed?